Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Handbook of Experimental Pharmacology
|
September 3, 2015
Functional Genomics in Pharmaceutical Drug Discovery
Robert Adams, Michael Steckel, Barbara Nicke
EMBO Reports
|
September 20, 2005
An RNA interference screen identifies Inhibitor of Apoptosis Protein 2 as a regulator of innate immune signalling in Drosophila
Viola Gesellchen, David Kuttenkeuler, Michael Steckel, et al.
Journal of Hematology & Oncology
|
June 30, 2019
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Krzysztof Brzezinka, Ekaterina Nevedomskaya, Ralf Lesche, et al.
Cell Research
|
May 23, 2012
Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies
Michael Steckel, Miriam Molina-Arcas, Britta Weigelt, et al.
Cell Death & Disease
|
March 31, 2017
Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death
Saskia Klutzny, Ralf Lesche, Matthias Keck, et al.
Cell
|
May 1, 2012
The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer
Madhu S Kumar, David C Hancock, Miriam Molina-Arcas, et al.
Genes & Development
|
November 2, 2005
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
Jae-Hyuck Shim, Changchun Xiao, Amber E Paschal, et al.
Journal of Hepatology
|
November 15, 2019
Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis
Zhaobing Ding, Russell E Ericksen, Nathalie Escande-Beillard, et al.
Iscience
|
September 14, 2020
Identification of Small Molecules that Modulate Mutant p53 Condensation
Clara Lemos, Luise Schulze, Joerg Weiske, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Handbook of Experimental Pharmacology
|
September 3, 2015
Functional Genomics in Pharmaceutical Drug Discovery
Robert Adams, Michael Steckel, Barbara Nicke
EMBO Reports
|
September 20, 2005
An RNA interference screen identifies Inhibitor of Apoptosis Protein 2 as a regulator of innate immune signalling in Drosophila
Viola Gesellchen, David Kuttenkeuler, Michael Steckel, et al.
Journal of Hematology & Oncology
|
June 30, 2019
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
Krzysztof Brzezinka, Ekaterina Nevedomskaya, Ralf Lesche, et al.
Cell Research
|
May 23, 2012
Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies
Michael Steckel, Miriam Molina-Arcas, Britta Weigelt, et al.
Cell Death & Disease
|
March 31, 2017
Functional inhibition of acid sphingomyelinase by Fluphenazine triggers hypoxia-specific tumor cell death
Saskia Klutzny, Ralf Lesche, Matthias Keck, et al.
Cell
|
May 1, 2012
The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer
Madhu S Kumar, David C Hancock, Miriam Molina-Arcas, et al.
Genes & Development
|
November 2, 2005
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
Jae-Hyuck Shim, Changchun Xiao, Amber E Paschal, et al.
Journal of Hepatology
|
November 15, 2019
Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis
Zhaobing Ding, Russell E Ericksen, Nathalie Escande-Beillard, et al.
Iscience
|
September 14, 2020
Identification of Small Molecules that Modulate Mutant p53 Condensation
Clara Lemos, Luise Schulze, Joerg Weiske, et al.
Page
of 1